Incheon, South Korea

Min Seob Lee

This inventor holds 2 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Celltrion Inc., Eone Diagnomics Genome Center Co., Ltd.. Active years: 2016-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Min Seob Lee. Retrieved from https://idiyas.com/inventor/min-seob-lee-nfx2rcx9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Min Seob Lee: Pioneering Advances in Fetal Diagnosis and Cancer Treatment

Introduction

Min Seob Lee, an accomplished inventor based in Incheon, South Korea, has made significant contributions to the fields of prenatal diagnosis and cancer treatment through his innovative inventions. With a total of two patents to his name, he has demonstrated a commitment to advancing medical technology that benefits patients globally.

Latest Patents

Min Seob Lee's latest patents are pivotal in their respective fields. The first patent, titled "Method capable of differentiating fetal sex and fetal sex chromosome abnormality on various platforms," introduces a groundbreaking method for diagnosing fetal sex chromosome aneuploidy. The invention addresses the challenges associated with differentiating conditions such as Klinefelter's syndrome (XXY), triple X syndrome (XXX), and Turner's syndrome (monosomy X, XO), along with the identification of male (XY) and female (XX) chromosomes. This method employs copy number variation (CNV) and offers enhanced sensitivity and accuracy through normalization of the reference line across different platforms. This noninvasive prenatal diagnosis technique enables early and accurate assessment of sex chromosome abnormalities with minimal fetal chromosome samples.

The second patent, titled "Dolastatin-10 derivative, method of producing the same and anticancer drug composition containing the same," presents a dolastatin-10 derivative known for its exceptional anticancer properties. This invention details a method for producing the derivative and formulates an anticancer drug composition where the dolastatin-10 derivative serves as the active ingredient, showcasing significant potential for cancer treatment.

Career Highlights

Throughout his career, Min Seob Lee has worked with notable companies in the biotechnology sector, including Eone Diagnomics Genome Center Co., Ltd. and Celltrion Inc. His contributions have not only helped advance the capabilities of these organizations but have also influenced the broader medical community.

Collaborations

Min Seob Lee has collaborated with distinguished individuals, including Chang Hyuk Kwon and Seon Young Yun. These partnerships have facilitated the development of cutting-edge technologies and have fostered innovation in their respective fields.

Conclusion

In summary, Min Seob Lee stands out as an inventor dedicated to improving healthcare through his innovative solutions. His patents in fetal diagnosis and cancer treatment highlight the importance of continuous research and development in advancing medical technologies. With his work, he paves the way for future discoveries that can transform patient care and treatment outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…